OncoCyte Corporation announced that effective June 24, 2022, Li Yu resigned as Vice President, Controller, and Principal Accounting Officer of the Company. Ms. Yu resigned to pursue other opportunities, and there were no disagreements between the Company and Ms. Yu on any matter regarding its operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | -4.95% | -4.61% | +7.60% |
May. 15 | Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
May. 15 | Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.60% | 35.95M | |
-36.44% | 8.68B | |
-3.29% | 3.2B | |
+19.31% | 2.71B | |
-18.71% | 2.04B | |
-22.03% | 1.64B | |
+64.58% | 1.43B | |
+34.58% | 841M | |
-7.42% | 718M | |
-25.51% | 538M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Announces Resignation of Li Yu as Controller and Principal Accounting Officer